Rising Kidney Stones To Boost Extracorporeal Shock Wave Lithotripsy Market Growth
Extracorporeal Shock Wave Lithotripsy Market by Technology (Electromagnetic,
Electrohydraulic, and Piezoelectric), Application (Kidney Stone, Pancreatic Stone,
and Other Applications), End-User (Hospital, Clinic, and Other End-Users), by
Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030
The Global Extracorporeal Shock Wave
Lithotripsy Market Is Estimated To Be Valued At US$ 340.09
Million In 2023 And Is Expected To Exhibit A CAGR Of 6.32 % Over The
Forecast Period, As Highlighted In A New Report Published By Coherent Market
Insights.
Market Overview:
Extracorporeal Shock Wave Lithotripsy is a non-operational therapy for renal
stones which can be conducted in the clinics, ambulatory center or mobile unit.
The method utilizes shock waves to divide into stone pieces which cannot flow
with urine. Extracorporeal Shock Wave Lithotripsy is efficient for many
individuals, however a small percent of stones may not be dissolved ample with
shock wave treatment and require other therapy. In these conditions,
lithotripsy will be utilized further to break up the stone pieces.
Competitive Landscape:
Key players involved in the growth of the global Extracorporeal Shock Wave Lithotripsy Market are Olympus, Cook
Medical, Richard-Wolf., Dornier MedTech and MTS Medical.
Market Key Drivers:
Increasing prevalence of kidney and ureter stones and rising minimally
invasive procedures is expected to boost the growth of the global
Extracorporeal Shock Wave Lithotripsy Market. For instance, as per a study
published in October 2021, around 5% of women and 12% of men are suffering from
kidney stones at some or the other point of life.
Rising product launches, mergers and acquisitions are anticipated to
drive the growth of the global Extracorporeal Shock Wave Lithotripsy Market.
For instance, in February 2023 ESWL was launched at BHR University Hospitals in
the UK and in September 2021, Boston Scientific entered an acquisition with
Lumenis LTD to create energy-based medical approaches for urology and
otolaryngology treatments.
Covid-19 Impact Analysis:
The Covid-19 outbreak has adversely affected the growth of the global Extracorporeal Shock Wave Lithotripsy
Market due to the surge in pandemic. The rising cases has shifted the focus
of physicians and the anesthetists towards curing the Covid-19 patients. Lack
of providers, postponement in the treatments and delay in appointments impeded
the market growth.
Key Takeaways:
The global Extracorporeal Shock
Wave Lithotripsy Market is anticipated to exhibit a CAGR of 6.32 % during
the forecast period owing to the rising prevalence of kidney stones, diabetes,
obesity and metabolic disorders. For instance, as per the International
Federation of Diabetics 2021, diabetes is a significant threat factor for
kidney stones, and it affected around 463 million people aged amid 20 to 79
years across the globe in 2020.
Among regions, North America, Europe and Asia Pacific are expected to
witness robust growth in global Extracorporeal Shock Wave Lithotripsy Market
due to rising prevalence of diabetes, metabolic disorders, kidney stones,
diabetes, increasing launches and approvals. For instance, as per the research
article published in the NLM, kidney stones affected around 600,000 in 2021 in
U.S.
Comments
Post a Comment